The Supreme Court on June 13 rejected a lawsuit challenging the Food and Drug Administration’s approach to regulating the abortion pill mifepristone with a ruling that will continue to allow the pills to be mailed to patients without an in-person doctor’s visit.
Mandatory Credit: Mandel Ngan/AFP/Getty Images via CNN Newsource
Stories this photo appears in:
Supreme Court rejects challenge to abortion pill mifepristone, allowing drug to stay on the market
The Supreme Court on Thursday rejected a lawsuit challenging the Food and Drug Administration’s approach to regulating the abortion pill mifepristone with a ruling that will continue to allow the pills to be mailed to patients without an in-person doctor’s visit.
